Rare diseases
Investigational molecules
Locations
Back to Romania37 clinical trials in Satu Mare, Romania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in RomaniaStudii.Clinice.ro(opens in a new tab)Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes
RomaniaStudy of maridebart cafraglutide to reduce cardiovascular problems in overweight or obese patients with atherosclerotic cardiovascular disease
RomaniaStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3
RomaniaStudy on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes
RomaniaStudy comparing cagrilintide and semaglutide versus tirzepatide in people with type 2 diabetes taking metformin or SGLT2 inhibitor
RomaniaA study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes
RomaniaComparing weekly insulin icodec and daily insulin glargine with insulin aspart in adults with type 1 diabetes: a 26-week study of blood sugar control
RomaniaStudy comparing semaglutide with insulin glargine in overweight adults with type 2 diabetes: effectiveness of combined treatment versus insulin alone
RomaniaStudy of Orforglipron for Adults with Type 2 Diabetes and Poor Blood Sugar Control on Insulin Glargine, with or without Metformin and/or SGLT-2 Inhibitor
RomaniaStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
RomaniaStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
RomaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on heart failure prevention and treatment of atrial fibrillation. Research includes evaluation of new combination therapies and interventions for reducing cardiovascular events.
Advanced trials examining novel therapeutic approaches for cardiovascular disease management and prevention.
Comprehensive research into Type 2 Diabetes and obesity treatments. Studies evaluate new medications for glycemic control and weight management.
Multiple therapeutic approaches being tested to improve patient outcomes in metabolic conditions.
Groundbreaking studies in non-alcoholic steatohepatitis (NASH) treatment. Trials focus on innovative therapies to improve liver health and prevent disease progression.
Advanced research aimed at developing effective treatments for chronic liver conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
